Apelin-17 vs Relaxin-2 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Apelin-17 is a 17-amino acid C-terminal fragment of the prepro-apelin precursor that binds and activates the APJ receptor (now APLNR) with the highest potency of all naturally occurring apelin isoforms. While apelin-13 is the best-characterized isoform, apelin-17 shows greater re...
Calculate Apelin-17 dose →Relaxin-2 (H2 Relaxin) is an endogenous peptide hormone of the insulin superfamily, best known for its roles in pregnancy physiology including cervical ripening, uterine quiescence, and connective tissue remodeling. Beyond reproduction, relaxin-2 is a systemic anti-fibrotic and v...
Calculate Relaxin-2 dose →| Parameter | Apelin-17 | Relaxin-2 |
|---|---|---|
| Category | Cardiovascular Peptide | Cardiovascular Peptide |
| Research | Preclinical / Phase I | Clinical |
| Half-Life | ~3-5 minutes IV (longer than apelin-13) | 10-15 min (plasma) |
| Typical Dose | 30-100 nmol/kg/min (IV infusion, clinical) | 30-300 mcg/kg/day (IV) |
| Frequency | Acute infusion protocols | Continuous 48-hour infusion (trials) |
| Route | IV infusion (clinical studies); SC under investigation | Intravenous (infusion) |
| FDA Status | Investigational (Phase I/II) | Not approved (Phase III completed) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.